Response to Ferket et al

Deborah Schofield¹, Luke Rynehart², Rupendra Shresthra¹, Susan M White^{3

4

5}, Zornitza Stark^{3

4

5}

Affiliations

¹ GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Department of Economics, Faculty of Business and Economics, Macquarie University, Sydney, NSW, Australia.
² GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Department of Economics, Faculty of Business and Economics, Macquarie University, Sydney, NSW, Australia. luke.rynehart@outlook.com.
³ Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
⁴ Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
⁵ Melbourne Genomics Health Alliance, Melbourne, VIC, Australia.

Free article

Comment

Deborah Schofield et al. Genet Med. 2020 Nov.

Free article

. 2020 Nov;22(11):1910.

doi: 10.1038/s41436-020-0889-z. Epub 2020 Jul 1.

Deborah Schofield¹, Luke Rynehart², Rupendra Shresthra¹, Susan M White^{3

4

5}, Zornitza Stark^{3

4

5}

¹ GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Department of Economics, Faculty of Business and Economics, Macquarie University, Sydney, NSW, Australia.
² GenIMPACT: Centre for Economic Impacts of Genomic Medicine, Department of Economics, Faculty of Business and Economics, Macquarie University, Sydney, NSW, Australia. luke.rynehart@outlook.com.
³ Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
⁴ Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
⁵ Melbourne Genomics Health Alliance, Melbourne, VIC, Australia.

No abstract available

Comment on

Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes.
Schofield D, Rynehart L, Shresthra R, White SM, Stark Z. Schofield D, et al. Genet Med. 2019 Nov;21(11):2586-2593. doi: 10.1038/s41436-019-0534-x. Epub 2019 May 21. Genet Med. 2019. PMID: 31110331
Economic value of exome sequencing for suspected monogenic disorders.
Ferket BS, Veenstra DL. Ferket BS, et al. Genet Med. 2020 Nov;22(11):1909. doi: 10.1038/s41436-020-0888-0. Epub 2020 Jun 30. Genet Med. 2020. PMID: 32601385 No abstract available.

1. Ferket BS, Veenstra DL. Economic value of exome sequencing for suspected monogenic disorders. Genet Med. 2020. https://doi.org/10.1038/s41436-020-0888-0
1. Schofield D, Rynehart L, Shresthra R, et al. Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes. Genet Med. 2019;21:2586–2593.
1. Stark Z, Lunke S, Brett GR, et al. Meeting the challenges of implementing rapid genomic testing in acute pediatric care. Genet Med. 2018;20:1554–1563. - PubMed
1. Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med. 2018;3:10. - PubMed - PMC